氨酸降低了代谢综合征的风险:随机对照试验的系统审查和元分析
Chih-Chen Tzang1, Liang-Yun Chi1, Long-Huei Lin2
1School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
Nutrition & diabetes
|May 16, 2024
概括
氨酸补充剂显著改善了主要代谢综合征 (MetS) 标志物,包括血压,禁食血糖和甘油三. 这表明 taurine 是一个有前途的饮食补充剂,用于管理 MetS 和减少相关的健康风险.
科学领域:
- 营养生物化学 营养生物化学
- 心血管健康 心血管健康
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢综合征 (MetS) 是一种复杂的疾病,其特点是存在一组风险因素,显著增加患心血管疾病和2型糖尿病的风险.
- 氨基酸陶因其在缓解MetS及其相关并发症方面的潜在治疗作用引起了人们的注意.
研究的目的:
- 通过对随机对照试验 (RCT) 的元分析,系统地评估 taurine 补充剂在改善 MetS 相关参数方面的疗效.
- 调查氨酸对MetS标记物的潜在剂量依赖作用,并评估身体组成和脂质配置文件等二次结果.
主要方法:
- 在主要数据库 (Embase,PubMed,Web of Science,Cochrane CENTRAL,ClinicalTrials.gov) 进行全面的文献搜索,截至2023年12月1日.
- 包括25个涉及1024名参与者的RCT,分析对静脉血压 (SBP),静脉血压 (DBP),禁食血糖 (FBG),甘油三 (TG) 和高密度脂蛋白胆固醇 (HDL-C) 的影响.
- 超回归分析以探索剂量-反应关系和评估二次结果,包括身体组成和脂质概况.
主要成果:
- 与对照组相比,氨酸补充剂显示SBP,DBP,FBG和TG在统计学上显著减少.
- 没有观察到对HDL-C水平的显著影响.
- 超回归表明DBP和FBG的剂量依赖性降低随着 taurine 剂量增加;没有报告显著的不良影响.
结论:
- 氨酸补充对与代谢综合征相关的多个关键因素产生积极影响.
- 氨酸对有风险或被诊断患有MetS的人来说是一个有前途的饮食干预措施.
- 需要进一步的研究来优化 taurine 的剂量策略,并评估其在 MetS 管理中的长期益处.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.7K
相关概念视频
01:19Overview of Carbohydrate Metabolism
944
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
944
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192